Global Safety Lancets for Diabetes Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Safety Lancets for Diabetes market size was valued at US$ 587 million in 2024 and is forecast to a readjusted size of USD 827 million by 2031 with a CAGR of 5.1% during review period.

Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.

The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.

This report is a detailed and comprehensive analysis for global Safety Lancets for Diabetes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Safety Lancets for Diabetes market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Safety Lancets for Diabetes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Safety Lancets for Diabetes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Safety Lancets for Diabetes market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Safety Lancets for Diabetes

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Safety Lancets for Diabetes market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, BD, Ascensia, Lifescan, B. Braun, Terumo, Nipro, Cardinal Health, ARKRAY, ICU Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Safety Lancets for Diabetes market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Safety Lancets with Needle

Safety Lancets with Blade

Market segment by Application

Hospital & Clinics

Home

Other

Major players covered

Roche

BD

Ascensia

Lifescan

B. Braun

Terumo

Nipro

Cardinal Health

ARKRAY

ICU Medical

Owen Mumford

HemoCue

Greiner Bio One

HTL-STREFA

Sarstedt

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Safety Lancets for Diabetes product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Safety Lancets for Diabetes, with price, sales quantity, revenue, and global market share of Safety Lancets for Diabetes from 2020 to 2025.

Chapter 3, the Safety Lancets for Diabetes competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Safety Lancets for Diabetes breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Safety Lancets for Diabetes market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Safety Lancets for Diabetes.

Chapter 14 and 15, to describe Safety Lancets for Diabetes sales channel, distributors, customers, research findings and conclusion.